Outcome of Patients With Metastatic Lung Neuroendocrine Tumors Submitted to First Line Monotherapy With Somatostatin Analogs

Outcome of Patients With Metastatic Lung Neuroendocrine Tumors Submitted to First Line Monotherapy With Somatostatin Analogs

ObjectiveAntiproliferative activity of somatostatin analogs (SSAs) has been demonstrated in digestive neuroendocrine tumors (NETs), but few data have been published in patients with pulmonary NETs. We therefore conducted a retrospective study to provide additional data on the outcome of patients wit...

Full description

Bibliographic Details
Main Authors: Elisa Lenotti, Andrea Alberti, Francesca Spada, Vito Amoroso, Patrick Maisonneuve, Salvatore Grisanti, Alice Baggi, Susanna Bianchi, Nicola Fazio, Alfredo Berruti
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-04-01
Series:Frontiers in Endocrinology
Subjects:
lung carcinoid
somatostatin analog
carcinoid syndrome
prognostic factor
distant metastases
Online Access:https://www.frontiersin.org/articles/10.3389/fendo.2021.669484/full

Internet

https://www.frontiersin.org/articles/10.3389/fendo.2021.669484/full

Similar Items